AliveCor Honored as one of FierceMedicalDevices’ Fierce 15 Most Promising Private Medical and Diagnostic Companies in the World

SAN FRANCISCO, Calif. October 21, 2014 – AliveCor, Inc. announced today that the company has been named one of the Fierce 15 most promising privately held medical device and diagnostic companies in the world. Editors select winners based on their top management teams, notable financial backing, promising technologies and market opportunities. The Fierce 15 celebrates the spirit of being fierce, championing innovation and creativity even in the face of intense competition. AliveCor was chosen because of its innovative work around the AliveCor® Heart Monitor, a mobile electrocardiogram (ECG) recorder that works in conjunction with the free AliveECG app. The app now includes an algorithm that can automatically detect for atrial fibrillation (AF), one of the most common heart rhythm disturbances. AliveCor’s AF Detector instantly detects if patients are experiencing AF through real-time ECG recordings so physicians can intervene before potentially life-threatening conditions, like strokes, occur.

“AliveCor exemplifies the growing use of technology in healthcare. Their new app and algorithm, which is cleared to detect AF, opens up exciting opportunities for the company and its customers, and enables personalized medicine. In the long-term, AliveCor hopes to further enhance treatment by gathering and utilizing Big Data to offer insights into AF via interpretation services,” said Varun Saxena, news editor, FierceMedicalDevices.

“The AliveCor team is honored to be selected as one of the leaders in our industry today. This great achievement is a true testament to the work we have done helping patients across the world as we strive to fulfill our vision for mobile health,” said Euan Thomson, president and chief executive officer at AliveCor. “Our goal at AliveCor is to create technologies that let patients take control of their own health in an easy, effective and clinically-proven way. The recent launch of our AF detector is the first of many algorithms we are developing to further enhance how our device can help detect, monitor and manage cardiac conditions and help save lives.”

The AliveCor Heart Monitor is intended to record, store and transfer ECG rhythms. The AliveCor Heart Monitor also displays ECG rhythms and detects the presence of atrial fibrillation (when prescribed or used under the care of a physician). The AliveCor Heart Monitor is intended for use by healthcare professionals, patients with known or suspected heart conditions and health-conscious individuals. The AliveCor Heart Monitor is compatible with all iOS models and most Android mobile devices. With secure storage in the cloud, users have the ability to access their data confidentially anytime, anywhere.

The AliveCor Heart Monitor’s medical grade ECG recordings can also be shared directly with a physician, or sent to a U.S. board-certified cardiologist or a U.S-based cardiac technician through a cloud-based ECG analysis service provided by AliveCor. In as little as 30 minutes users can receive expert reviews of their ECGs directly through the AliveECG app providing a more complete picture of their current heart health.

The AliveCor Heart Monitor can be purchased at www.alivecor.com.